170 related articles for article (PubMed ID: 26958841)
1. Prostate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential New Biomarkers.
Duscharla D; Bhumireddy SR; Lakshetti S; Pospisil H; Murthy PV; Walther R; Sripadi P; Ummanni R
PLoS One; 2016; 11(3):e0150253. PubMed ID: 26958841
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S
J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726
[TBL] [Abstract][Full Text] [Related]
3. Correlation of lipidomic composition of cell lines and tissues of breast cancer patients using hydrophilic interaction liquid chromatography/electrospray ionization mass spectrometry and multivariate data analysis.
Cífková E; Lísa M; Hrstka R; Vrána D; Gatěk J; Melichar B; Holčapek M
Rapid Commun Mass Spectrom; 2017 Feb; 31(3):253-263. PubMed ID: 27862481
[TBL] [Abstract][Full Text] [Related]
4. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
Guo S; Qiu L; Wang Y; Qin X; Liu H; He M; Zhang Y; Li Z; Chen X
Anal Bioanal Chem; 2014 Jul; 406(18):4357-70. PubMed ID: 24842401
[TBL] [Abstract][Full Text] [Related]
5. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
6. Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics.
Zhou X; Mao J; Ai J; Deng Y; Roth MR; Pound C; Henegar J; Welti R; Bigler SA
PLoS One; 2012; 7(11):e48889. PubMed ID: 23152813
[TBL] [Abstract][Full Text] [Related]
7. Identification of plasma lipid species as promising diagnostic markers for prostate cancer.
Chen X; Zhu Y; Jijiwa M; Nasu M; Ai J; Dai S; Jiang B; Zhang J; Huang G; Deng Y
BMC Med Inform Decis Mak; 2020 Sep; 20(Suppl 9):223. PubMed ID: 32967667
[TBL] [Abstract][Full Text] [Related]
8. Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry.
Sogno I; Conti M; Consonni P; Noonan DM; Albini A
Rapid Commun Mass Spectrom; 2012 May; 26(10):1213-8. PubMed ID: 22499197
[TBL] [Abstract][Full Text] [Related]
9. A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer.
Patel N; Vogel R; Chandra-Kuntal K; Glasgow W; Kelavkar U
PLoS One; 2014; 9(3):e88841. PubMed ID: 24603597
[TBL] [Abstract][Full Text] [Related]
10. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
Skytt A; Thysell E; Stattin P; Stenman UH; Antti H; Wikström P
Int J Cancer; 2007 Aug; 121(3):615-20. PubMed ID: 17410539
[TBL] [Abstract][Full Text] [Related]
11. Size Dependent Lipidomic Analysis of Urinary Exosomes from Patients with Prostate Cancer by Flow Field-Flow Fractionation and Nanoflow Liquid Chromatography-Tandem Mass Spectrometry.
Yang JS; Lee JC; Byeon SK; Rha KH; Moon MH
Anal Chem; 2017 Feb; 89(4):2488-2496. PubMed ID: 28192938
[TBL] [Abstract][Full Text] [Related]
12. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
13. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of arachidonic acid metabolites change during prostate cancer progression.
Rodríguez-Blanco G; Burgers PC; Dekker LJ; Ijzermans JJ; Wildhagen MF; Schenk-Braat EA; Bangma CH; Jenster G; Luider TM
Prostate; 2014 May; 74(6):618-27. PubMed ID: 24435810
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of detecting prostate cancer by ultraperformance liquid chromatography-mass spectrometry serum metabolomics.
Zang X; Jones CM; Long TQ; Monge ME; Zhou M; Walker LD; Mezencev R; Gray A; McDonald JF; Fernández FM
J Proteome Res; 2014 Jul; 13(7):3444-54. PubMed ID: 24922590
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
17. Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status.
Snider AJ; Seeds MC; Johnstone L; Snider JM; Hallmark B; Dutta R; Moraga Franco C; Parks JS; Bensen JT; Broeckling CD; Mohler JL; Smith GJ; Fontham ETH; Lin HK; Bresette W; Sergeant S; Chilton FH
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 33007922
[TBL] [Abstract][Full Text] [Related]
18. The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer.
Wach S; Al-Janabi O; Weigelt K; Fischer K; Greither T; Marcou M; Theil G; Nolte E; Holzhausen HJ; Stöhr R; Huppert V; Hartmann A; Fornara P; Wullich B; Taubert H
Int J Cancer; 2015 Sep; 137(6):1406-16. PubMed ID: 25754273
[TBL] [Abstract][Full Text] [Related]
19. Shotgun lipidomics for candidate biomarkers of urinary phospholipids in prostate cancer.
Min HK; Lim S; Chung BC; Moon MH
Anal Bioanal Chem; 2011 Jan; 399(2):823-30. PubMed ID: 20953865
[TBL] [Abstract][Full Text] [Related]
20. Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy.
Matthews Q; Jirasek A; Lum JJ; Brolo AG
Phys Med Biol; 2011 Nov; 56(21):6839-55. PubMed ID: 21971286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
